KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY BE A THERAPEUTIC TARGET. (12th June 2019)

• Record Type: Journal Article
• Authors: Cheminant, M.; Decroos, A.; Bruneau, J.; Carras, S.; Pelletier, L.; Martin, N.; Peri, V.; Guillot, F.; Paturel, C.; Sicard, H.; Bonnafous, C.; Lhermitte, L.; Molina, T.; Asnafi, V.; Genestier, L.; Gaulard, P.; Ortonne, N.; Hermine, O.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 204
• Page End: 205
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.21_2630
• Languages: English
• ISSNs: 0278-0232